VOYA Investment Management
RXRX icon

VOYA Investment Management’s Recursion Pharmaceuticals RXRX Stock Holding History

VOYA Investment Management’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$360K Buy
97,983
+21,200
+28% +$70.6K ﹤0.01% 1973
2026
Q1 		$236K Buy
76,783
+11,471
+18% +$44.3K ﹤0.01% 2055
2025
Q4 		$267K Buy
65,312
+2,144
+3% +$10.6K ﹤0.01% 2029
2025
Q3 		$308K Sell
63,168
-28,874
-31% -$152K ﹤0.01% 1974
2025
Q2 		$466K Buy
92,042
+25,352
+38% +$125K ﹤0.01% 1935
2025
Q1 		$353K Sell
66,690
-8,030
-11% -$58.5K ﹤0.01% 2035
2024
Q4 		$505K Sell
74,720
-392
-0.5% -$2.64K ﹤0.01% 1930
2024
Q3 		$495K Buy
75,112
+6,421
+9% +$46K ﹤0.01% 2002
2024
Q2 		$515K Sell
68,691
-57,601
-46% -$502K ﹤0.01% 1987
2024
Q1 		$1.26M Buy
126,292
+44,550
+55% +$496K ﹤0.01% 1531
2023
Q4 		$806K Sell
81,742
-554
-0.7% -$3.95K ﹤0.01% 1804
2023
Q3 		$630K Buy
82,296
+27,615
+51% +$275K ﹤0.01% 1914
2023
Q2 		$408K Buy
54,681
+2,076
+4% +$14.5K ﹤0.01% 2200
2023
Q1 		$351K Hold
52,605
– – ﹤0.01% 2243
2022
Q4 		$406K Hold
52,605
– – ﹤0.01% 2147
2022
Q3 		$560K Buy
52,605
+1,325
+3% +$13.4K ﹤0.01% 1958
2022
Q2 		$417K Buy
+51,280
New +$343K ﹤0.01% 1955
2022
Q1 		– Sell
-42,851
Closed -$734K – 2738
2021
Q4 		$734K Buy
42,851
+31,591
+281% +$594K ﹤0.01% 1755
2021
Q3 		$259K Buy
11,260
+3,089
+38% +$87.5K ﹤0.01% 2420
2021
Q2 		$298K Buy
+8,171
New +$242K ﹤0.01% 2381

Other funds holding RXRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

VOYA Investment Management's RXRX Position: Q2 2026 in Review

VOYA Investment Management increased its Recursion Pharmaceuticals (RXRX) stake by 28% in Q2 2026, buying an estimated $70.6K and bringing the position to 97,983 shares worth $360K. The position accounts for ﹤0.01% of the portfolio, ranked #1973.

VOYA Investment Management first reported a position in RXRX in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.26M in Q1 2024. 343 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

  • VOYA Investment Management held 97,983 shares of Recursion Pharmaceuticals worth $360K as of Q2 2026.
  • VOYA Investment Management bought 21,200 Recursion Pharmaceuticals shares in Q2 2026, an estimated $70.6K.
  • Recursion Pharmaceuticals made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #1973 holding.
  • VOYA Investment Management first reported a position in Recursion Pharmaceuticals in Q2 2021 and has held it in 20 quarters since.
  • VOYA Investment Management's Recursion Pharmaceuticals position peaked at $1.26M in Q1 2024.
  • 343 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.